In this global Phase 3 kidney disease study spanning 10 countries across Europe, North America, and Oceania, our Home Trial Support (HTS) service played a vital role in improving patient access and retention.
Over a 12+ month treatment period, 278 patients were referred to HTS, and our team conducted 1,685 home visits, helping participants manage demanding care routines from the comfort of home. Click the link below to read the full case study.